Conversano Ciro, Orrù Graziella, Pozza Andrea, Miccoli Mario, Ciacchini Rebecca, Marchi Laura, Gemignani Angelo
Department of Surgical, Medical and Molecular Pathology, Critical and Care Medicine, University of Pisa, 56126 Pisa, Italy.
Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
Int J Environ Res Public Health. 2021 Mar 11;18(6):2882. doi: 10.3390/ijerph18062882.
: Hypertension is among the most important risk factors for cardiovascular diseases, which are considered high mortality risk medical conditions. To date, several studies have reported positive effects of mindfulness-based stress reduction (MBSR) interventions on physical and psychological well-being in other medical conditions, but no meta-analysis on MBSR programs for hypertension has been conducted. Objectives: The objective of this study was to determine the effectiveness of MBSR programs for hypertension. : A systematic review and meta-analysis of randomized controlled trials examining the effects of MBSR on systolic and diastolic blood pressure (BP), anxiety, depression, and perceived stress in people with hypertension or pre-hypertension was conducted. The PubMed/MEDLINE and PsycINFO databases were searched in November 2020 to identify relevant studies. : Six studies were included. The comparison of MBSR versus control conditions on diastolic BP was associated with a statistically significant mean effect size favoring MBSR over control conditions ( = -2.029; 95% confidence interval (CI): -3.676 to -0.383, = 0.016, = 6; 22 effect sizes overall), without evidence of heterogeneity ( = 0.000%). The comparison of MBSR versus control conditions on systolic BP was associated with a mean effect size which was statistically significant only at a marginal level ( = -3.894; 95% CI: -7.736-0.053, = 0.047, = 6; 22 effect sizes overall), without evidence of high heterogeneity ( = 20.772%). The higher the proportion of participants on antihypertensive medications was, the larger the effects of MBSR were on systolic BP ( = -0.750, = -2.73, = 0.003). : MBSR seems to be a promising intervention, particularly effective on the reduction of diastolic BP. More well-conducted trials are required.
高血压是心血管疾病最重要的危险因素之一,心血管疾病被认为是高死亡风险的病症。迄今为止,多项研究报告了基于正念减压疗法(MBSR)的干预措施对其他病症患者身心健康的积极影响,但尚未对高血压的MBSR项目进行荟萃分析。目的:本研究的目的是确定MBSR项目对高血压的有效性。:对研究MBSR对高血压或高血压前期患者收缩压和舒张压(BP)、焦虑、抑郁和感知压力影响的随机对照试验进行了系统评价和荟萃分析。2020年11月检索了PubMed/MEDLINE和PsycINFO数据库以识别相关研究。:纳入了六项研究。MBSR与对照条件在舒张压方面的比较显示,有利于MBSR而非对照条件的平均效应大小具有统计学意义(=-2.029;95%置信区间(CI):-3.676至-0.383,=0.016,=6;总共22个效应大小),没有异质性证据(=0.000%)。MBSR与对照条件在收缩压方面的比较显示,平均效应大小仅在边缘水平具有统计学意义(=-3.894;95%CI:-7.736 - 0.053,=0.047,=6;总共22个效应大小),没有高异质性证据(=20.772%)。服用抗高血压药物的参与者比例越高,MBSR对收缩压的影响越大(=-0.750,=-2.73,=0.003)。:MBSR似乎是一种有前景的干预措施,对降低舒张压特别有效。需要更多设计良好的试验。